MICHAEL BROWN: Open Payments
NPI 1306874276 · WAYNESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 67 payments from 18 companies in 2025. Trend: 2023 $1,943 · 2024 $1,829 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $275 |
| PFIZER INC. | 9 | $196 |
| Lilly USA, LLC | 10 | $180 |
| ABBVIE INC. | 5 | $93 |
| Novartis Pharmaceuticals Corporation | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $54 |
| Exact Sciences Corporation | 3 | $44 |
| Amgen Inc. | 2 | $38 |
Products named: NURTEC ODT, MOUNJARO, FARXIGA, LEQVIO, AIRSUPRA, NEXIUM, Kerendia, REXULTI.
Industry payments across NC — which companies pay providers there.
